BamSEC and AlphaSense Join Forces
Learn More

Stoke Therapeutics Inc. – Transcripts

NASDAQ: STOK    
Share price (9/22/26): $29.20    
Market cap (9/22/26): $1.884 billion
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 08/04/26 Stoke Therapeutics, Inc., Q2 2026 Earnings Call, Aug 03, 2026 08/03/26
Other Revised 06/08/26 Stoke Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM 06/08/26
Earnings Revised 05/25/26 Stoke Therapeutics, Inc., Q1 2026 Earnings Call, May 07, 2026 05/07/26
CY 2025
Earnings Revised 09/23/25 Stoke Therapeutics, Inc., Q2 2025 Earnings Call, Aug 12, 2025 08/12/25
Other Revised 01/15/25 Stoke Therapeutics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:00 PM 01/15/25
CY 2022
Other Revised 11/14/22 Stoke Therapeutics, Inc. - Shareholder/Analyst Call 11/14/22
Other Revised 01/10/22 Stoke Therapeutics, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 04:30 PM 01/10/22
CY 2019
Other Revised 12/04/19 Stoke Therapeutics, Inc. Presents at Piper Jaffray 31st Annual Healthcare Conference, Dec-04-2019 11:50 AM 12/04/19
Other Revised 11/20/19 Stoke Therapeutics, Inc. Presents at Stifel 2019 Healthcare Conference, Nov-20-2019 04:10 PM 11/20/19
Other Revised 11/12/19 Stoke Therapeutics, Inc. Presents at Credit Suisse 28th Annual Healthcare Conference, Nov-12-2019 04:10 PM 11/12/19